Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Treatment Delays Costly in HIV

November 23, 2010 6:17 am | News | Comments

HIV infected patients whose treatment is delayed not only become sicker than those treated earlier, but also require tens of thousands of dollars more in care over the first several years of their treatment.

TOPICS:

Half of Depression Suffers Stop Meds

November 23, 2010 6:16 am | News | Comments

Most patients who take anti-depressants give up their treatment in less than six months, the minimum period recommended for treating severe depression and only 25% continue their treatment for more than 11 months.

TOPICS:

New Tool in Fight Against Ebola

November 23, 2010 6:13 am | News | Comments

Boston University researchers have developed a simple diagnostic tool that can quickly identify dangerous viruses like Ebola and Marburg. The biosensor is the size of a quarter and can detect viruses in a blood sample.

TOPICS:
Advertisement

Gene Protects Cancer from Chemo

November 23, 2010 6:12 am | News | Comments

Researchers at Virginia Commonwealth University have discovered that a gene well known for its involvement in tumor cell development, growth and metastasis also protects cancer cells from being destroyed by chemotherapy.

TOPICS:

3D Cell Culture

November 22, 2010 7:49 am | Drug Discovery & Development | Product Releases | Comments

Reinnervate has announced the first commercial launch of alvetex, its 3D cell culture technology. Alvetex provides a robust and inert scaffold for cells to grow and form complex 3D cell structures, mimicking the normal growth and formation of tissues.

TOPICS:

Recirculating Chillers

November 22, 2010 7:43 am | Product Releases | Comments

Thermo Fisher Scientific Inc. has introduced the ThermoChill I and ThermoChill II re-circulating chillers. These compact, floor-standing re-circulating chillers provide a temperature range of 5 to 30°C and have a cooling capacity from 700 to 2000 W.

TOPICS:

Rare Disease Reveals Path to Stem Cells

November 22, 2010 7:35 am | News | Comments

Researchers at Harvard Medical School and the Harvard School of Dental Medicine have found that by mimicking a rare genetic disorder in a dish, they can rewind the internal clock of a mature cell and drive it back into an adult stem-cell stage.

TOPICS:

Normal Tissue Turned Into 3D Cancer

November 22, 2010 7:31 am | News | Comments

Researchers have successfully transformed normal human tissue into three-dimensional cancers in a tissue culture dish for the first time. Watching how the cells behave as they divide and invade surrounding tissue will help physicians better understand how human cancers act in the body.

TOPICS:
Advertisement

Trana Receives Qualifying Therapeutic Grants

November 22, 2010 7:21 am | News | Comments

Trana Discovery, Inc., announced that its anti-HIV 201 HTS Drug Discovery Assay and the Staphylococcus aureus Antibiotic Drug Discovery Assay, qualified to receive federal grant funding under the Patient Protection and Affordable Care Act.

TOPICS:

Abbott Releases Atrasentan Results

November 22, 2010 7:12 am | News | Comments

Abbott announced positive results from a Phase 2 dose-ranging study of atrasentan, a highly selective endothelin A receptor antagonist in development to help slow chronic kidney disease progression in patients with type 2 diabetic nephropathy.

TOPICS:

Omthera Reaches Agreement With FDA

November 22, 2010 7:09 am | News | Comments

Omthera Pharmaceuticals, Inc. has reached an agreement with the U.S. Food and Drug Administration on a Special Protocol Assessment for the design of its Phase 3 registration clinical trial of Epanova, for the treatment of patients with very high triglycerides.

TOPICS:

South Africans Abuse AIDS Drugs

November 22, 2010 6:57 am | by Donna Bryson | News | Comments

AIDS patients in South Africa are being robbed of their lifesaving drugs so that they can be mixed with marijuana and smoked, authorities and health experts say. The concoction is called "whoonga" and it adds a bizarre twist to the war on AIDS.

TOPICS:

UN Worries It May Have Caused Cholera Outbreak

November 22, 2010 6:55 am | by Jonathan M. Katz | News | Comments

It began as a rumor that farmers saw waste from a U.N. peacekeeping base flow into a river. Within days of the talk, hundreds downstream had died from cholera.

TOPICS:

PRA International Opens Bioanalytical Lab

November 22, 2010 5:31 am | News | Comments

PRA International announced the opening a new bioanalytical laboratory in Lenexa, Kan., to support the company’s early-phase study capabilities in the United States.

TOPICS:

Blowdown Station

November 19, 2010 7:30 am | Product Releases | Comments

Porvair Sciences Ltd. has announced that a leading manufacturer of ready-made oligonucleotides, with bases in both North America and Europe, has standardized on their Ultravap Blowdown Station for careful drying of their production samples.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading